Cardiovascular calcification is the leading health disorder that leads to the passive degenerative process mainly occurring due to deterioration of tissues caused by the stress and strain of cardiac function. It is observed that it is highly prevalent in patients with chronic kidney disease and is predictive of cardiovascular disease (CVD).
Cardiovascular calcification is triggered by chronic inflammatory disorders such as chronic kidney disease (CKD), type 2 diabetes (T2D), and atherosclerosis that are associated with high prevalence of morbidity and mortality. As of now there are no drug therapies against cardiovascular calcification, the only treatment option is surgery. Some of the risk factors associated with Cardiovascular Calcification includes age, sex, pulse pressure, number of pack-years of smoking, systolic blood pressure, diabetes mellitus, waist circumference, kidney function and many others.
DelveInsight's "Cardiovascular Calcification Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the Cardiovascular Calcification Market, historical and forecasted epidemiology, the pipeline insight as well as the Cardiovascular Calcification market size and shares analysis in the seven major markets (7MM) (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Cardiovascular Calcification Market Analysis
The Cardiovascular Calcification market analysis section of the report helps to build the detailed comprehension of the historic, current and forecasted Cardiovascular Calcification market trends and growth by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Cardiovascular Calcification market size and shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Cardiovascular Calcification Epidemiology Forecast
The Cardiovascular Calcification epidemiology section covers insights about historical and current Cardiovascular Calcification patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Cardiovascular Calcification Pipeline Analysis and Key Companies
The Cardiovascular Calcification Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cardiovascular Calcification market or expected to get launched in the market during the study period. The analysis covers the Cardiovascular Calcification key companies and market uptake by drugs; patient uptake by therapies; and sales of each drug.
For more details on Cardiovascular Calcification Market Insights, Epidemiology, and Pipeline Analysis, visit: https://www.delveinsight.com/report-store/cardiovascular-calcification-market